Shortcomings halt study of Swiss cancer vaccine.
Schiermeier
Quirin
Q
D019496:Cancer Vaccines / Q000276:immunology / Q000592:standards* / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence* / Q000592:standards*; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D007258:Informed Consent; D020407:Internet; D008545:Melanoma / Q000276:immunology* / Q000628:therapy*; D015337:Multicenter Studies as Topic; D013557:Switzerland; D016896:Treatment Outcome
D019496:Cancer Vaccines